Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 383

2.

Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus.

Earnshaw DL, Bacon TH, Darlison SJ, Edmonds K, Perkins RM, Vere Hodge RA.

Antimicrob Agents Chemother. 1992 Dec;36(12):2747-57.

3.

Mode of action of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl) cycloprop-1'-yl]methyl]guanine (A-5021) against herpes simplex virus type 1 and type 2 and varicella-zoster virus.

Ono N, Iwayama S, Suzuki K, Sekiyama T, Nakazawa H, Tsuji T, Okunishi M, Daikoku T, Nishiyama Y.

Antimicrob Agents Chemother. 1998 Aug;42(8):2095-102.

4.

[Effect and mechanism of beta-L-D4A (a novel nucleoside analog) against hepatitis B virus].

Wu JM, Lin JS, Xie N, Jiang FC, Liang KH.

Zhonghua Gan Zang Bing Za Zhi. 2003 May;11(5):268-70. Chinese.

PMID:
12773236
5.

The mechanism of inhibition of hepatitis B virus replication by the carbocyclic analog of 2'-deoxyguanosine.

Price PM, Banerjee R, Jeffrey AM, Acs G.

Hepatology. 1992 Jul;16(1):8-12.

PMID:
1319957
6.
7.
8.

Activity of penciclovir in antiviral assays against herpes simplex virus.

Bacon TH, Howard BA, Spender LC, Boyd MR.

J Antimicrob Chemother. 1996 Feb;37(2):303-13.

PMID:
8707740
9.

Enhanced oral absorption and antiviral activity of 1-O-octadecyl-sn-glycero-3-phospho-acyclovir and related compounds in hepatitis B virus infection, in vitro.

Hostetler KY, Beadle JR, Kini GD, Gardner MF, Wright KN, Wu TH, Korba BA.

Biochem Pharmacol. 1997 Jun 15;53(12):1815-22.

PMID:
9256156
10.

Efficacies of entecavir against lamivudine-resistant hepatitis B virus replication and recombinant polymerases in vitro.

Levine S, Hernandez D, Yamanaka G, Zhang S, Rose R, Weinheimer S, Colonno RJ.

Antimicrob Agents Chemother. 2002 Aug;46(8):2525-32.

11.

Inhibitory activity of dioxolane purine analogs on wild-type and lamivudine-resistant mutants of hepadnaviruses.

Seignères B, Pichoud C, Martin P, Furman P, Trépo C, Zoulim F.

Hepatology. 2002 Sep;36(3):710-22.

PMID:
12198665
12.

Broad-spectrum antiviral activity of the acyclic guanosine phosphonate (R,S)-HPMPG.

Terry BJ, Mazina KE, Tuomari AV, Haffey ML, Hagen M, Feldman A, Slusarchyk WA, Young MG, Zahler R, Field AK.

Antiviral Res. 1988 Dec 1;10(4-5):235-51.

PMID:
2852486
13.

In vitro activities of penciclovir and acyclovir against herpes simplex virus types 1 and 2.

Weinberg A, Bate BJ, Masters HB, Schneider SA, Clark JC, Wren CG, Allaman JA, Levin MJ.

Antimicrob Agents Chemother. 1992 Sep;36(9):2037-8.

14.

In vitro inhibition of hepadnavirus polymerases by the triphosphates of BMS-200475 and lobucavir.

Seifer M, Hamatake RK, Colonno RJ, Standring DN.

Antimicrob Agents Chemother. 1998 Dec;42(12):3200-8.

15.
16.

Generation of stable cell lines expressing Lamivudine-resistant hepatitis B virus for antiviral-compound screening.

Walters KA, Tipples GA, Allen MI, Condreay LD, Addison WR, Tyrrell L.

Antimicrob Agents Chemother. 2003 Jun;47(6):1936-42.

18.
20.

Mechanism of inhibition of duck hepatitis B virus polymerase by (-)-beta-L-2',3'-dideoxy-3'-thiacytidine.

Severini A, Liu XY, Wilson JS, Tyrrell DL.

Antimicrob Agents Chemother. 1995 Jul;39(7):1430-5.

Supplemental Content

Support Center